Get the Stockscreener App
2.24
3.03%
-0.07
After Hours:
2.20
-0.04
-1.79%
Pmgc Holdings Inc stock is traded at $2.24, with a volume of 56,768.
It is down -3.03% in the last 24 hours and up +4.67% over the past month.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
See More
Previous Close:
$2.31
Open:
$2.31
24h Volume:
56,768
Relative Volume:
0.06
Market Cap:
$2.94M
Revenue:
$2.45M
Net Income/Loss:
$-5.47M
P/E Ratio:
-0.0379
EPS:
-59.1634
Net Cash Flow:
$-6.05M
1W Performance:
+3.23%
1M Performance:
+4.67%
6M Performance:
-9.68%
1Y Performance:
-98.04%
1-Day Range:
$2.19
$2.3166
1-Week Range:
$2.11
$2.40
52-Week Range:
$0.6273
$119.98
Pmgc Holdings Inc Stock (ELAB) Company Profile
Name
Pmgc Holdings Inc
Sector
Industry
Phone
888-445-4886
Address
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare ELAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAB
Pmgc Holdings Inc
|
2.24 | 2.94M | 2.45M | -5.47M | -6.05M | -59.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmgc Holdings Inc Stock (ELAB) Latest News
PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph
Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan
Northstrive Biosciences Announces Initiation of Phase II of - GlobeNewswire
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases - Stock Titan
Daily Progress: PMGC Holdings Inc (ELAB) Drop -0.96, Closing at 2.06 - DWinneX
Market Recap: Next Technology Holding Inc (NXTT)’s Positive Momentum, Closing at 1.40 - DWinneX
PMGC signs LOI to acquire California-based CNC machining company By Investing.com - Investing.com South Africa
PMGC signs LOI to acquire California-based CNC machining company - Investing.com Australia
PMGC Holdings Inc. Enters Non-Binding LOI to Acquire California-Based CNC Machining Company Specializing in Aerospace and Defense - Nasdaq
TKO Group President Mark Shapiro Headlines JP Morgan Conference: Key Strategic Updates Expected - Stock Titan
PMGC Holdings Inc. Signs Letter of Intent to Acquire - GlobeNewswire
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years - Yahoo Finance
PMGC Holdings Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - I-Connect007
PMGC Holdings to acquire U.S. electronics manufacturer By Investing.com - Investing.com South Africa
PMGC Plans to Acquire US-based Electronics Manufacturing Firm; Shares Rise - MarketScreener
PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure By Stocktwits - Investing.com India
PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure - Asianet Newsable
PMGC Holdings to acquire U.S. electronics manufacturer - Investing.com Australia
PMGC signs LOI to acquire electronics contract manufacturing company - TipRanks
PMGC Holdings Inc. Signs Letter of Intent to Acquire High-Precision Electronics Manufacturing Company - Nasdaq
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - GlobeNewswire
PMGC Holdings Expands PCB Manufacturing Empire with Second Strategic Acquisition Since April - Stock Titan
Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline By Investing.com - Investing.com South Africa
Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline - Investing.com Australia
Northstrive Biosciences completes phase I research on muscle-wasting treatment - Investing.com
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia - GlobeNewswire
Northstrive Biosciences Amends License Agreement with MOA Life - TipRanks
PMGC Holdings Inc. Files Quarterly Report for Q1 2025, Highlights Strategic Growth Initiatives - Nasdaq
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q - The Manila Times
PMGC Holdings Expands into Hot GLP-1 Market While Pursuing Tech Acquisition: Q1 2025 Details Released - Stock Titan
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market - ADVFN
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire
PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan
PMGC Holdings inks employee secondment deal with Northstrive By Investing.com - Investing.com Nigeria
PMGC Holdings inks employee secondment deal with Northstrive - Investing.com
Northstrive Biosciences Signs Binding Term Sheet with - GlobeNewswire
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22 - Stock Titan
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance - ADVFN
PMGC Holdings Inc: Navigating Market Fluctuations with a 2.72M Market Cap - investchronicle.com
ELAB’s price-to-free cash flow ratio: How it affects investment decisions - uspostnews.com
PMGC Holdings (ELAB) Continues Uptrend During Pre-Hours On Positive Sentiment - Stocks Telegraph
ELAB Stock Price and Chart — NASDAQ:ELAB - TradingView
RESENDNorthstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - GlobeNewswire
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - The Manila Times
Northstrive Biosciences Strengthens IP Portfolio with New - GlobeNewswire
Northstrive Expands Patent Portfolio: New GLP-1 Combo Treatment Could Prevent Muscle Loss in Obesity - Stock Titan
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial - The Manila Times
Northstrive Biosciences Co-Founder Featured on Bear Bull - GlobeNewswire
Pmgc Holdings Inc Stock (ELAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):